Detection of inguinal lymph node involvement in penile squamous cell carcinoma by 18F-fluorodeoxyglucose PET/CT: A prospective single-center study

Urologic Oncology: Seminars and Original Investigations

Volumn 30, Issue 1, 2012, Pages 55-59

  Schlenker, Boris ^a   Scher, Bernhard ^b   Tiling, Reinhold ^a   Siegert, Sabine ^c   Hungerhuber, Edwin ^a   Gratzke, Christian ^a   Tilki, Derya ^a   Reich, Oliver ^a   Schneede, Peter ^d   Bartenstein, Peter ^a   Stief, Christian G ^a   Seitz, Michael ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b KLINIKUM BOGENHAUSEN   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d Hospital Memmingen   (Germany)

Author keywords

FDG PET CT; Lymph node involvement; Penile carcinoma; Squamous cell carcinoma

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INGUINAL LYMPH NODE; LYMPH NODE METASTASIS; MALE; PENIS CARCINOMA; PENIS SQUAMOUS CELL CARCINOMA; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FLUORODEOXYGLUCOSE F18; HUMANS; INGUINAL CANAL; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PENILE NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOISOTOPES; SENSITIVITY AND SPECIFICITY;

EID: 84855679234     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2009.10.012     Document Type: Article

References (29)

1. Bleeker M.C., Heideman D.A., Snijders P.J., et al. Penile cancer: Epidemiology, pathogenesis, and prevention. World J Urol 2009, 27:141-150.
2. Derakhshani P., Neubauer S., Braun M., et al. Results and 10-year follow-up in patients with squamous cell carcinoma of the penis. Urol Int 1999, 62:238-244.
3. Misra S., Chaturvedi A., Misra N.C. Penile carcinoma: A challenge for the developing world. Lancet Oncol 2004, 5:240-247.
4. Ornellas A.A., Kinchin E.W., Nobrega B.L., et al. Surgical treatment of invasive squamous cell carcinoma of the penis: Brazilian National Cancer Institute long-term experience. J Surg Oncol 2008, 97:487-495.
5. Ornellas A.A., Nobrega B.L., Wei Kin Chin E., et al. Prognostic factors in invasive squamous cell carcinoma of the penis: Analysis of 196 patients treated at the Brazilian National Cancer Institute. J Urol 2008, 180:1354-1359.
6. Cubilla A.L. The role of pathologic prognostic factors in squamous cell carcinoma of the penis. World J Urol 2009, 27:169-177.
7. Hughes B., Leijte J., Shabbir M., et al. Noninvasive and minimally invasive staging of regional lymph nodes in penile cancer. World J Urol 2009, 27:197-203.
8. Leijte J.A.P., Hughes B., Kroon B.K., et al. Multi-institutional evaluation of dynamic sentinel node biopsy for penile carcinoma. Eur Urol 2008, 7(Suppl):110.
9. Hadway P., Smith Y., Corbishley C., et al. Evaluation of dynamic lymphoscintigraphy and sentinel lymph-node biopsy for detecting occult metastases in patients with penile squamous cell carcinoma. BJU Int 2007, 100:561-565.
10. Hungerhuber E., Schlenker B., Karl A., et al. Risk stratification in penile carcinoma: 25-year experience with surgical inguinal lymph node staging. Urology 2006, 68:621-625.
11. Solsona E., Algaba F., Horenblas S., et al. EAU guidelines on penile cancer. Eur Urol 2004, 46:1-8.
12. Algaba F., Horenblas S., Pizzocaro-Luigi Piva G., et al. EAU guidelines on penile cancer. Eur Urol 2002, 42:199-203.
13. Scher B., Seitz M., Reiser M., et al. 18F-FDG PET/CT for staging of penile cancer. J Nucl Med 2005, 46:1460-1465.
14. Horenblas S. Lymphadenectomy for squamous cell carcinoma of the penis. Part 2: The role and technique of lymph node dissection. BJU Int 2001, 88:473-483.
15. Stahl A., Weber W.A., Avril N., et al. Effect of N-butylscopolamine on intestinal uptake of fluorine-18-fluorodeoxyglucose in PET imaging of the abdomen. Nuklearmedizin 2000, 39:241-245.
16. Ornellas A.A., Seixas A.L., Marota A., et al. Surgical treatment of invasive squamous cell carcinoma of the penis: Retrospective analysis of 350 cases. J Urol 1994, 151:1244-1249.
17. Lont A.P., Besnard A.P., Gallee M.P., et al. A comparison of physical examination and imaging in determining the extent of primary penile carcinoma. BJU Int 2003, 91:493-495.
18. Zhu Y., Zhang S.L., Ye D.W., et al. Predicting pelvic lymph node metastases in penile cancer patients: A comparison of computed tomography, Cloquet's node, and disease burden of inguinal lymph nodes. Onkologie 2008, 31:37-41.
19. Tabatabaei S., Harisinghani M., McDougal W.S. Regional lymph node staging using lymphotropic nanoparticle enhanced magnetic resonance imaging with ferumoxtran-10 in patients with penile cancer. J Urol 2005, 174:923-927. Discussion 27.
20. Spiess P.E., Izawa J.I., Bassett R., et al. Preoperative lymphoscintigraphy and dynamic sentinel node biopsy for staging penile cancer: Results with pathological correlation. J Urol 2007, 177:2157-2161.
21. Leijte J., Hughes B., Kroon B., et al. Multi-institutional evaluation of dynamic sentinel node biopsy for penile carcinoma. Eur Urol Suppl 2008, 7:110.
22. Perdona S., Autorino R., Gallo L., et al. Role of dynamic sentinel node biopsy in penile cancer: Our experience. J Surg Oncol 2006, 93:181-185.
23. Horenblas S., Jansen L., Meinhardt W., et al. Detection of occult metastasis in squamous cell carcinoma of the penis using a dynamic sentinel node procedure. J Urol 2000, 163:100-104.
24. Perdona S., Autorino R., De Sio M., et al. Dynamic sentinel node biopsy in clinically node-negative penile cancer versus radical inguinal lymphadenectomy: A comparative study. Urology 2005, 66:1282-1286.
25. Ficarra V., Galfano A. Should the dynamic sentinel node biopsy (DSNB) be considered the gold standard in the evaluation of lymph node status in patients with penile carcinoma?. Eur Urol 2007, 52:17-19. Discussion 20-1.
26. Hungerhuber E., Schlenker B., Frimberger D., et al. Lymphoscintigraphy in penile cancer: Limited value of sentinel node biopsy in patients with clinically suspicious lymph nodes. World J Urol 2006, 24:319-324.
27. Kitajima K., Murakami K., Yamasaki E., et al. Accuracy of 18F-FDG PET/CT in detecting pelvic and paraaortic lymph node metastasis in patients with endometrial cancer. AJR Am J Roentgenol 2008, 190:1652-1658.
28. Leijte J.A., Graafland N.M., Valdes Olmos R.A., et al. Prospective evaluation of hybrid (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in staging clinically node-negative patients with penile carcinoma. BJU Int 2009, 104:640-644.
29. Graafland N.M., Leijte J.A., Valdes Olmos R.A., et al. Scanning with 18F-FDG-PET/CT for detection of pelvic nodal involvement in inguinal node-positive penile carcinoma. Eur Urol 2009, 56:339-345.